In this second of a series of three webinars focussing on obesity, hosted by ABCD and GIRFT and supported by Novo Nordisk Ltd, Professor Barbara McGowan will present an update on current and future obesity services in the UK, and Susannah Howard will talk about the commissioning perspective.
ABCD would like to announce these two QI opportunities from the NDA team for diabetes services and CCG/Healthboards to our members. Please note the tight deadline of 21st April 2021.
Effect of empagliflozin on albuminuria, eGFR and serum creatinine: updated results from the ABCD national empagliflozin audit. Thomas SJ Crabtree1, Alex Bickerton2, Jackie Elliot3, Rajeev Raghavan4, Dennis Barnes5, Siva Sivappriyan6, Suzanne Phillips7, Alison Evans7, Devesh Sennik8, Anurita Rohilla9, Ian Gallen10, Robert EJ Ryder11 on behalf of the ABCD Empagliflozin Audit Contributors. British Journal of Diabetes Vol 21 14/04/2021
Due to the pressure on hospital teams during the COVID pandemic, we have postponed the 2021 competition but are launching a revamped award for 2022 which has been amended to take into account the current COVID situation. We are inviting colleagues to submit entries which will be for:
‘The Rowan Hillson Inpatient Safety Award – The best interventions: Redesigning, rebuilding and maintaining safe inpatient diabetes care during COVID’
In this first of a series of three webinars focussing on obesity, hosted by ABCD and GIRFT and supported by Novo Nordisk Ltd, Professor Carel le Roux will present strategies for preventing diabetes with intentional weight loss.
This is a Novo Nordisk Sponsored meeting
The Joint British Diabetes Societies (JBDS) for Inpatient Care group was created in 2008 to ‘deliver a set of diabetes inpatient guidelines and proposed standards of care within secondary care organisations’, with the overall aim of improving inpatient diabetes care through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.
The National Inpatient Diabetes COVID19 Response Group has published guidance for healthcare professionals on managing hyperglycaemia/diabetes in a COVID Virtual Ward for patients with or without diabetes. This is to support safe management of hyperglycaemia in those receiving glucocorticoid treatment for COVID-19 infection outside of a hospital environment.
